Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Positron-Emission Tomography”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06344767
What this trial is testing

Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor

Who this might be right for
Breast Cancer
Fudan University 19
Not applicableEnded earlyNCT05471271
What this trial is testing

IL-2 PET Imaging in Advanced Solid Tumours

Who this might be right for
Metastatic Solid Tumor
University Medical Center Groningen 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT07059832
What this trial is testing

Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors

Who this might be right for
Cancer
First Hospital of China Medical University 30
Not applicableActive Not RecruitingNCT06523777
What this trial is testing

PRISM: Patient Experiences With PET Imaging in Prostate Cancer

Who this might be right for
Prostate Cancer
Yale University 350
Early research (Phase 1)Ended earlyNCT03059563
What this trial is testing

Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users

Who this might be right for
Dopamine D2/3 Receptor AvailabilityCognitive FunctionMethamphetamine Abuse
University of California, Los Angeles 62
Not applicableEnded earlyNCT02700763
What this trial is testing

[18F]Dabrafenib Molecular Imaging in Melanoma Brain Metastasis

Who this might be right for
Melanoma
University Medical Center Groningen 1
Not applicableActive Not RecruitingNCT00194298
What this trial is testing

FDG-PET Imaging in Complicated Diabetic Foot

Who this might be right for
Diabetic Foot Disease
University of Pennsylvania 240
Not applicableWithdrawnNCT01789892
What this trial is testing

Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer

Who this might be right for
Lung Cancer
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT05407311
What this trial is testing

64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Clarity Pharmaceuticals Ltd 53
Not applicableLooking for participantsNCT06584357
What this trial is testing

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more
GAP Innovations, PBC 1,200
Not applicableStudy completedNCT00867412
What this trial is testing

Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerThoracotomy
Rigshospitalet, Denmark 189
Not applicableStudy completedNCT00002981
What this trial is testing

PET Scan in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 173
Not applicableUnknownNCT04343469
What this trial is testing

Effects of Morbid Obesity and Bariatric Surgery on Brain Inflammation, and Activation of Central Reward System

Who this might be right for
Morbid Obesity
Turku University Hospital 90
Not applicableStudy completedNCT01240681
What this trial is testing

Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy

Who this might be right for
Locally Advanced Breast Cancer (LABC)
Ontario Clinical Oncology Group (OCOG) 32
Not applicableNot Yet RecruitingNCT07440212
What this trial is testing

Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging

Who this might be right for
Esophagus Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 50
Not applicableStudy completedNCT00729092
What this trial is testing

Additional Positron Emission Tomography (PET) Scan of Brain in Patients Undergoing PET Scan for Diseases Unrelated to Brain

Who this might be right for
Pain
Asokumar Buvanendran 100
Large-scale testing (Phase 3)Study completedNCT01930812
What this trial is testing

18F-NaF PET Imaging for Bone Scintigraphy

Who this might be right for
Bone Metastases From Breast or Prostate Cancer
British Columbia Cancer Agency 286
Not applicableStudy completedNCT02443766
What this trial is testing

Use of a Functional Neuroimaging Battery for the Evaluation of a Meditation Retreat

Who this might be right for
Healthy
Thomas Jefferson University 14
Early research (Phase 1)Study completedNCT00968656
What this trial is testing

Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1

Who this might be right for
Breast CancerHead and Neck CancerDiffuse Large B-cell Lymphoma
Washington University School of Medicine 31
Testing effectiveness (Phase 2)Study completedNCT05635045
What this trial is testing

Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR

Who this might be right for
Transthyretin Amyloidosis
Columbia University 10
Next Page